ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

Autor: Fey, M. F., Greil, R., Jost, L. M.

Publikováno v: Fey, M. F.; Greil, R.; Jost, L. M. (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients. Annals of oncology, 16(suppl_1), i48-i49. Oxford University Press 10.1093/annonc/mdi802

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ddcf6239f2bd58da34aba5e62df0a94
https://doi.org/10.1093/annonc/mdi802

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Autor: Bohlius, J, Tonia, T, Nüesch, E, Jüni, P, Fey, M F, Egger, M, Bernhard, J

Publikováno v: British Journal of Cancer; 7/8/2014, Vol. 111 Issue 1, p33-45, 13p

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1.

Autor: Jenal, M., Batliner, J., Reddy, V. A., Haferlach, T., Tobler, A., Fey, M. F., Torbett, B. E., Tschan, M. P.

Publikováno v: Leukemia (08876924); May2010, Vol. 24 Issue 5, p1073-1076, 4p, 3 Graphs

DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function.

Autor: Britschgi, A., Trinh, E., Rizzi, M., Jenal, M., Ress, A., Tobler, A., Fey, M. F., Helin, K., Tschan, M. P.

Publikováno v: Oncogene; 9/25/2008, Vol. 27 Issue 43, p5706-5716, 11p, 2 Black and White Photographs, 4 Graphs

The hDMP1 tumor suppressor is a new WT1 target in myeloid leukemias.

Autor: Tschan, M. P., Gullberg, U., Shan, D., Torbett, B. E., Fey, M. F., Tobler, A.

Publikováno v: Leukemia (08876924); May2008, Vol. 22 Issue 5, p1087-1090, 4p, 2 Graphs